Mesh : COVID-19 / blood complications Child Computed Tomography Angiography Electrocardiography Fibrinolytic Agents / therapeutic use Heparin / therapeutic use Hospitalization Humans Intensive Care Units, Pediatric Male Nephrotic Syndrome / complications Patient Readmission Pediatric Obesity / complications Pulmonary Embolism / blood complications diagnosis drug therapy Pulmonary Heart Disease / diagnosis drug therapy etiology SARS-CoV-2 Tachypnea Thrombophilia / blood complications drug therapy Tissue Plasminogen Activator / therapeutic use Vomiting

来  源:   DOI:10.1016/j.ajem.2021.04.014   PDF(Sci-hub)   PDF(Pubmed)

Abstract:
The pediatric population accounts for a small portion of those with severe disease related to COVID-19. There are few published reports of hypercoagulable states in children with COVID-19. We describe an 11-year-old male with nephrotic syndrome who required inpatient treatment for COVID-19 pneumonia eight weeks prior. He returned to the emergency department with vomiting, tachypnea and was found to have a pulmonary embolism. In this case report, we discuss the risk factors for, presentation and evaluation of hypercoagulable state and its relation to COVID-19 in a pediatric patient.
摘要:
儿科人群占与COVID-19相关的严重疾病人群的一小部分。关于COVID-19儿童高凝状态的报道很少。我们描述了一名11岁的肾病综合征男性,八周前需要住院治疗COVID-19肺炎。他呕吐回到急诊室,呼吸急促,被发现有肺栓塞。在这个案例报告中,我们讨论的风险因素,儿科患者高凝状态及其与COVID-19的关系的介绍和评估。
公众号